Bharat Biotech's nasal Covid vaccine to be introduced as booster dose
Dec 23, 2022, at 04:32 am
New Delhi/IBNS: Bharat Biotech’s nasal Covid vaccine, iNCOVACC, will be introduced as a booster dose as the government gears up to avert a fresh wave of coronavirus, media reports said.
The news of rising COVID cases coming out of China is concerning: SII CEO Adar Poonawalla
Dec 21, 2022, at 08:42 pm
Mumbai: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday expressed concern over the rising COVID-19 cases in China and said the issue is 'concerning'.
COVID-19: Covishield and Covaxin prices slashed to Rs 225 per dose for Pvt centres
Apr 09, 2022, at 10:57 pm
New Delhi: A day before the rollout of precaution doses for the population aged between 18 and 59 years, the Covid-19 vaccine manufacturers have slashed the price of jabs by more than half.
Jun 26, 2021, at 06:18 am
Pune/IBNS: The Serum institute of India, which started manufacturing the first batch of Novavax's Covid-19 vaccine in India under the name Covavax, said "a new milestone has been reached".
Serum Institute to sell Covishield to states at Rs. 400, private hospitals at Rs. 600
Apr 21, 2021, at 07:17 pm
Pune/IBNS: The Serum Institute of India (SII) has decided to sell one dose of its Covid-19 vaccine, named Covishield, to state governments at Rs. 400 and private hospitals at Rs. 600, as India will enter into a liberalised vaccination drive from May 1.
India commits to ship Covishield vaccines to Canada within a month
Feb 16, 2021, at 04:46 am
Canada/IBNS: Adar Poonawalla, the chief executive of Serum Institute of India (SII), confirmed on Monday that Covishield vaccines would be shipped to Canada within a month.
India fights COVID-19: First consignment of Covishield vaccines leaves Serum Institute Pune
Jan 12, 2021, at 04:25 pm
Pune/UNI: Three temperature-controlled trucks rolled out of the Serum Institute's gates shortly before 5 am and left for Pune airport, from where the vaccines will be flown to different parts of India.
Serum Institute gets DCGI nod to resume Covid-19 vaccine
Sep 16, 2020, at 04:25 pm
New Delhi/IBNS: The Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, media reports said.